These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6980088)

  • 1. Cytotoxic T cell hybridomas: generation and characterization.
    Eshhar Z; Waks T; Oren T; Berke G; Kaufmann Y
    Curr Top Microbiol Immunol; 1982; 100():11-8. PubMed ID: 6980088
    [No Abstract]   [Full Text] [Related]  

  • 2. LYT-2 negative and T cell growth factor independent cytotoxic T lymphocyte hybridomas.
    Kaufmann Y
    Adv Exp Med Biol; 1982; 146():435-46. PubMed ID: 6980569
    [No Abstract]   [Full Text] [Related]  

  • 3. Lectin-dependent cytolytic and cytolymic T helper clones and hybridomas.
    Lindahl KF; Nordin AA; Schreier MH
    Curr Top Microbiol Immunol; 1982; 100():1-10. PubMed ID: 6980086
    [No Abstract]   [Full Text] [Related]  

  • 4. An attempt to produce "pre-T" cell hybridomas and to identify their antigens.
    Aihara Y; Bühring HJ; Aihara M; Klein J
    Eur J Immunol; 1986 Nov; 16(11):1391-9. PubMed ID: 3096743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of murine thymus cells: correlation of surface phenotype with the appearance of cytolytic T lymphocyte precursors.
    Ceredig R; MacDonald HR
    Prog Clin Biol Res; 1982; 85 Pt A():443-9. PubMed ID: 6125945
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of class II MHC molecules in the activation of class I-reactive T cell hybridomas.
    Minami M; Nariuchi H; Kawasaki H; Dorf ME
    J Immunol; 1986 May; 136(9):3341-5. PubMed ID: 2420887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of hybridoma macrophages.
    Martin CA; Falkenberg F; Willmer U; Liu YN; Uchida T; Ju ST; Dorf ME
    Ann Inst Pasteur Immunol (1985); 1986; 137C(2):240-44. PubMed ID: 3089127
    [No Abstract]   [Full Text] [Related]  

  • 8. Culture conditions that optimize outgrowth of hybridomas.
    Hamilton MJ; Davis WC
    Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
    [No Abstract]   [Full Text] [Related]  

  • 9. CT hybridomas: tumor cells capable of lysing virally infected target cells.
    Whitaker RB; Kauffman RS; Che M; Finberg R
    J Immunol; 1982 Aug; 129(2):900-3. PubMed ID: 6282974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the anti-self + TNP immune response: T cell lines, clones and hybridomas.
    Schmitt-Verhulst AM; Cooley MA; Guimezanes A; De Préval C; Albert F; Buferne M
    Curr Top Microbiol Immunol; 1982; 100():125-34. PubMed ID: 6980089
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2 antigens incorporated into phospholipid vesicles elicit specific allogeneic cytotoxic T lymphocytes.
    Hale AH
    Cell Immunol; 1980 Oct; 55(2):328-41. PubMed ID: 6159109
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies.
    MacDonald HR; Lees RK; Bron C
    J Immunol; 1985 Dec; 135(6):3944-50. PubMed ID: 2415592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired H-2-specific monoclonal antibodies react differently to red cells and lymphocytes.
    Tonkonogy SL; Amos DB
    Immunogenetics; 1981 Dec; 14(6):497-505. PubMed ID: 7319569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of novel killer hybridomas derived from proliferation-suppressed somatic cell hybrids between YACUT T cell lymphoma and normal lymphocytes activated in secondary mixed lymphocyte cultures.
    Kubota K; Nakazato K; Tamauchi H; Sasahara T; Katoh H
    J Immunol Methods; 1996 Jun; 192(1-2):137-47. PubMed ID: 8699010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human T antigens in interspecies hybridomas.
    Weiner DB; Watson SR; Babcock G; Keller SJ
    Cell Immunol; 1986 Jun; 100(1):197-209. PubMed ID: 2943408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An IL 2-secreting T cell hybridoma that responds to a self class I histocompatibility antigen in the H-2D region.
    Endres RO; Marrack P; Kappler JW
    J Immunol; 1983 Oct; 131(4):1656-62. PubMed ID: 6604749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.
    van Dongen JJ; Geurts van Kessel AH; Wolvers-Tettero IL; Versnel MA; van Oudenaren A; Schoenmaker E; Hagemeijer A
    J Immunol; 1986 Aug; 137(3):1047-53. PubMed ID: 3487584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity assays based on the use of antibody secretion as a measure of hybridoma viability.
    Marbrook J
    Methods Enzymol; 1986; 121():759-71. PubMed ID: 3523138
    [No Abstract]   [Full Text] [Related]  

  • 20. CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding.
    Renard V; Romero P; Vivier E; Malissen B; Luescher IF
    J Exp Med; 1996 Dec; 184(6):2439-44. PubMed ID: 8976201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.